Academic Journal
Q1Kidney Medicine
About Kidney Medicine
Kidney Medicine is a scholarly journal published by Elsevier Inc.. SCImago 2025 lists it in Q1, with an SJR of 1.305 and H-index of 36.
Coverage: 2019-2026. Research categories: Internal Medicine (Q1); Nephrology (Q1).
Open-access policies and author information
Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2026-04-27. This snapshot does not establish today’s listing status or fee quotation.
Publisher policy links recorded by DOAJ
- Aims and scope ↗
- Editorial board ↗
- Instructions for authors ↗
- Peer-review policy ↗
- Publication fees ↗
- Fee waivers ↗
- Licence terms ↗
- Copyright policy ↗
- Preservation policy ↗
Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.
Source-backed journal facts
Topics in published research
Dialysis and Renal Disease Management; Chronic Kidney Disease and Diabetes; Renal Diseases and Glomerulopathies; Acute Kidney Injury Research; Renal Transplantation Outcomes and Treatments; Organ Donation and Transplantation.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
When Transplant Tourism Returns to the United States: Clinical and Ethical Challenges
Veena Ganesan, Jacob M. Appel, Dinushika Mohottige, Susan Lerner et al.
2026-11 · DOI: 10.1016/j.xkme.2026.101493Taurolidine-Induced Anaphylaxis—A Problem Occurring More Than Once
Lisa Christina Horvath, Christine Bangert, Georg Gelbenegger, Bernd Jilma et al.
2026-11 · DOI: 10.1016/j.xkme.2026.101508Risk for Kidney Failure in Heterozygous Autosomal Alport Syndrome: Environmental Factors versus Genetics—Evidence From Separated Monozygotic Twins
Jan Boeckhaus, Ludwig Patzer, Sima Jami, Oliver Gross et al.
2026-10 · DOI: 10.1016/j.xkme.2026.101557Cost-Effectiveness of Dapagliflozin in the Treatment of Patients With Chronic Kidney Disease in Denmark
Thea Tanderup Kjær, Morten Lindhardt, Anders Hammerich Riis, Henrik Birn et al.
2026-10 · DOI: 10.1016/j.xkme.2026.101497Risk Prediction of Incident Chronic Kidney Disease Using Plasma Proteomics in Individuals Without Diabetes
Momen Abbasi, Celestin Missikpode, Ashish Verma, Runqi Zhao et al.
2026-10 · DOI: 10.1016/j.xkme.2026.101556Anti-Contactin-1-Associated Membranous Nephropathy Presenting With Subsequent Autoimmune Nodopathy
Ruben Visch, Shoko Vos, Pierre Ronco, Hanna Debiec et al.
2026-10 · DOI: 10.1016/j.xkme.2026.101478Risk of Progression and Costs of Care for Patients With Chronic Kidney Disease
Navdeep Tangri, Rakesh Singh, Keith A. Betts, Yuxian Du et al.
2026-10 · DOI: 10.1016/j.xkme.2026.101484Barriers to Use of Cardio-Kidney Protective Medications in Chronic Kidney Disease: Results of a Nephrology Provider Survey
Melanie R. Weltman, Linda-Marie U. Lavenburg, Margaret F. Zupa, Manisha Jhamb et al.
2026-10 · DOI: 10.1016/j.xkme.2026.101474Rituximab as Rescue Therapy for Atezolizumab-Induced IgA Vasculitis
Cristina R. Ortiz, Jose Arriola-Montenegro, Sanjeev Sethi, Sandra M. Herrmann et al.
2026-10 · DOI: 10.1016/j.xkme.2026.101481Neighborhood Disadvantage and Dementia Risk Among Older Patients With Kidney Failure: Differences by Race/Ethnicity and Urbanicity
Yiting Li, Gayathri Menon, Jane J. Long, Byoungjun Kim et al.
2026-10 · DOI: 10.1016/j.xkme.2026.101479Vitamin D Supplementation Associated With Alterations in Lipid Metabolism in Children With Glomerular Disease
Denise C. Hasson, Aditya Surapaneni, Michal L. Melamed, Christine B. Sethna et al.
2026-10 · DOI: 10.1016/j.xkme.2026.101506Association of Kidney Tubule Dysfunction and Injury Biomarkers With Long-term Risk of Acute Kidney Injury During Acute Congestive Heart Failure Hospitalizations
Henry E. Wang, Jennifer A. Frey, Ashutosh Tamhane, Lauren Shingler et al.
2026-10 · DOI: 10.1016/j.xkme.2026.101466Neuroendocrine Tumors May be Associated With Atypical Cystic Disease of the Kidneys or Liver
Rohail Jameel, Doaa E. Elbarougy, Conrad Cruz, Hana Yang et al.
2026-10 · DOI: 10.1016/j.xkme.2026.101554Humoral and Cellular Immune Responses Following Bivalent SARS-CoV-2 mRNA Vaccines in Patients Undergoing Hemodialysis: A Prospective Cohort Study
Tsai-Chieh Ling, Po-Lin Chen, Jen-Ren Wang, Wen-Chien Ko et al.
2026-10 · DOI: 10.1016/j.xkme.2026.101480Patients’ Attitudes on the Use of Expanded Outreach to Find a Kidney Donor: A Mixed-Methods Study
Anne Solbu, Renee B. Cadzow, Maria Keller, Rhys Mendel et al.
2026-10 · DOI: 10.1016/j.xkme.2026.101486Effects of Losartan, Empagliflozin, and Their Combination on Uric Acid Concentrations in People With Type 2 Diabetes
Danii L.S. Suijk, Preciosa X.C. Simson, Rosalie A. Scholtes, Charlotte M. Mosterd et al.
2026-10 · DOI: 10.1016/j.xkme.2026.101436Are We Missing the Mark? Program Leadership Perceptions of Nephrology Career Choice
Georges N. Nakhoul, Amy S. Nowacki, Elias Bassil, Joseph Hajj et al.
2026-10 · DOI: 10.1016/j.xkme.2026.101501Dialyzer Reactions Revisited: A Fresh Perspective
Charles Jun Han Ng, Roy Debajyoti Malakar
2026-10 · DOI: 10.1016/j.xkme.2026.101475Real-world Evidence for Improvements in Inflammation and Anemia Biomarkers After the Initiation of GLP-1RA in Patients Receiving Hemodialysis
Suman Lama, Sheetal Chaudhuri, Derek Blankenship, Andrea Nandorine Ban et al.
2026-10 · DOI: 10.1016/j.xkme.2026.101476Effects of Lanthanum Carbonate on Whole-Body Phosphorus and Calcium Balance in Adults With Chronic Kidney Disease and Normophosphatemia
Anna Jovanovich, Michel Chonchol, Taylor Struemph, Tyson J. Marden et al.
2026-10 · DOI: 10.1016/j.xkme.2026.101496Reviews
Community Reviews
Version History
September 25, 2026 at 7:39 am
September 25, 2026